Supraventricular tachycardia in pregnancy: Cardioversion with verapamil

Victor Klein, John Repke

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Cardiac arrhythmias are not uncommon during pregnancy. The supraventricular tachyarrhythmias have been treated successfully with digoxin, propanolol, overdrive atrial pacing, electrocardioversion, and most recently with verapamil. Verapamil is the prototype calcium channel blocker. Its use in pregnancy has been limited though the experimental effects of verapamil on fetal heart activity and uterine contractility have been studied. Reported is a case of a digitalized hyperthyroid pregnant patient successfully treated with verapamil for supraventricular tachycardia. Continuous electronic fetal monitoring was used during the period of cardioversion. The excellent response to verapamil with its apparent absence of adverse maternal or fetal side effects would suggest that the use of verapamil in the treatment of supraventricular arrhythmias in pregnancy is safe and effective.

Original languageEnglish (US)
Pages (from-to)16S-18S
JournalObstetrics and Gynecology
Volume63
Issue number3
StatePublished - Jan 1 1984

Fingerprint

Electric Countershock
Supraventricular Tachycardia
Verapamil
Pregnancy
Cardiac Arrhythmias
Cardiotocography
Fetal Heart
Fetal Movement
Digoxin
Calcium Channel Blockers
Hyperthyroidism
Tachycardia
Propranolol
Mothers

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

@article{ac311ac569b94d34a0af1047d8bfe944,
title = "Supraventricular tachycardia in pregnancy: Cardioversion with verapamil",
abstract = "Cardiac arrhythmias are not uncommon during pregnancy. The supraventricular tachyarrhythmias have been treated successfully with digoxin, propanolol, overdrive atrial pacing, electrocardioversion, and most recently with verapamil. Verapamil is the prototype calcium channel blocker. Its use in pregnancy has been limited though the experimental effects of verapamil on fetal heart activity and uterine contractility have been studied. Reported is a case of a digitalized hyperthyroid pregnant patient successfully treated with verapamil for supraventricular tachycardia. Continuous electronic fetal monitoring was used during the period of cardioversion. The excellent response to verapamil with its apparent absence of adverse maternal or fetal side effects would suggest that the use of verapamil in the treatment of supraventricular arrhythmias in pregnancy is safe and effective.",
author = "Victor Klein and John Repke",
year = "1984",
month = "1",
day = "1",
language = "English (US)",
volume = "63",
pages = "16S--18S",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Supraventricular tachycardia in pregnancy : Cardioversion with verapamil. / Klein, Victor; Repke, John.

In: Obstetrics and Gynecology, Vol. 63, No. 3, 01.01.1984, p. 16S-18S.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Supraventricular tachycardia in pregnancy

T2 - Cardioversion with verapamil

AU - Klein, Victor

AU - Repke, John

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Cardiac arrhythmias are not uncommon during pregnancy. The supraventricular tachyarrhythmias have been treated successfully with digoxin, propanolol, overdrive atrial pacing, electrocardioversion, and most recently with verapamil. Verapamil is the prototype calcium channel blocker. Its use in pregnancy has been limited though the experimental effects of verapamil on fetal heart activity and uterine contractility have been studied. Reported is a case of a digitalized hyperthyroid pregnant patient successfully treated with verapamil for supraventricular tachycardia. Continuous electronic fetal monitoring was used during the period of cardioversion. The excellent response to verapamil with its apparent absence of adverse maternal or fetal side effects would suggest that the use of verapamil in the treatment of supraventricular arrhythmias in pregnancy is safe and effective.

AB - Cardiac arrhythmias are not uncommon during pregnancy. The supraventricular tachyarrhythmias have been treated successfully with digoxin, propanolol, overdrive atrial pacing, electrocardioversion, and most recently with verapamil. Verapamil is the prototype calcium channel blocker. Its use in pregnancy has been limited though the experimental effects of verapamil on fetal heart activity and uterine contractility have been studied. Reported is a case of a digitalized hyperthyroid pregnant patient successfully treated with verapamil for supraventricular tachycardia. Continuous electronic fetal monitoring was used during the period of cardioversion. The excellent response to verapamil with its apparent absence of adverse maternal or fetal side effects would suggest that the use of verapamil in the treatment of supraventricular arrhythmias in pregnancy is safe and effective.

UR - http://www.scopus.com/inward/record.url?scp=0021342096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021342096&partnerID=8YFLogxK

M3 - Article

C2 - 6700874

AN - SCOPUS:0021342096

VL - 63

SP - 16S-18S

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -